Literature DB >> 22190299

Hematoma risk after needle electromyography.

Andrea J Boon1, Jon T Gertken, James C Watson, Ruple S Laughlin, Jeffrey A Strommen, Michelle L Mauermann, Eric J Sorenson.   

Abstract

INTRODUCTION: Although needle electromyography (EMG) appears to be a relatively safe procedure based primarily on clinical experience, no evidence-based guidelines exist for EMG procedures in patients taking anticoagulant or antiplatelet medications. We sought to determine whether there is an increased risk of hematoma formation after EMG of potentially high-risk muscles in patients taking anticoagulant or antiplatelet agents.
METHODS: After undergoing routine EMG, if any of seven predetermined high-risk muscles were tested, study subjects then underwent ultrasound to evaluate for hematoma formation.
RESULTS: Patients were divided into three groups based on medication (warfarin, aspirin/clopidogrel, no blood-thinning medication), with at least 100 muscles examined per group. Two small, subclinical hematomas were seen on ultrasound; there was no difference in hematoma risk between groups (P = 0.43).
CONCLUSIONS: Our findings suggest that hematoma formation from standard needle EMG is rare even in high-risk muscles, which have been avoided historically in anticoagulated patients.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22190299     DOI: 10.1002/mus.22227

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

Review 1.  A Focused Review of Safety Considerations in Cancer Rehabilitation.

Authors:  Susan Maltser; Adrian Cristian; Julie K Silver; G Stephen Morris; Nicole L Stout
Journal:  PM R       Date:  2017-09       Impact factor: 2.298

2.  Knowledge of electromyography (EMG) in patients undergoing EMG examinations.

Authors:  Mauro Mondelli; Alessandro Aretini; Giuseppe Greco
Journal:  Funct Neurol       Date:  2014 Jul-Sep

3.  Review of needle electromyography complications in thrombocytopenic cancer patients.

Authors:  Mazen Zein; Sudhakar Tummala; Laura Prince; Jack B Fu
Journal:  Muscle Nerve       Date:  2022-02-01       Impact factor: 3.217

4.  Survey of Botulinum Toxin Injections in Anticoagulated Patients: Korean Physiatrists' Preference in Controlling Anticoagulation Profile Prior to Intramuscular Injection.

Authors:  Yongjun Jang; Geun-Young Park; Jihye Park; Asayeon Choi; Soo Yeon Kim; Chris Boulias; Chetan P Phadke; Farooq Ismail; Sun Im
Journal:  Ann Rehabil Med       Date:  2016-04-25

Review 5.  Potential risks of iatrogenic complications of nerve conduction studies (NCS) and electromyography (EMG).

Authors:  A Gechev; N M Kane; M Koltzenburg; D G Rao; R van der Star
Journal:  Clin Neurophysiol Pract       Date:  2016-10-13

6.  Needle EMG induced muscle bleeding complication after guideline approved discontinuation of anticoagulation.

Authors:  Michael Bartl; Arne Krahn; Joachim Riggert; Walter Paulus
Journal:  Clin Neurophysiol Pract       Date:  2021-03-26

Review 7.  Dry Needling and Antithrombotic Drugs.

Authors:  María Muñoz; Jan Dommerholt; Sara Pérez-Palomares; Pablo Herrero; Sandra Calvo
Journal:  Pain Res Manag       Date:  2022-01-07       Impact factor: 3.037

Review 8.  Needle EMG muscle identification: A systematic approach to needle EMG examination.

Authors:  Daniel L Menkes; Robert Pierce
Journal:  Clin Neurophysiol Pract       Date:  2019-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.